Clenbuterol: A Potent Bronchodilator for Respiratory Relief
| Product dosage: 40mcg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $4.02 | $40.15 (0%) | 🛒 Add to cart |
| 20 | $3.51 | $80.30 $70.26 (12%) | 🛒 Add to cart |
| 30 | $2.84 | $120.45 $85.32 (29%) | 🛒 Add to cart |
| 60 | $1.89 | $240.90 $113.42 (53%) | 🛒 Add to cart |
| 90 | $1.66 | $361.35 $149.56 (59%) | 🛒 Add to cart |
| 120 | $1.42 | $481.80 $170.64 (65%) | 🛒 Add to cart |
| 180 | $1.36 | $722.70 $243.91 (66%) | 🛒 Add to cart |
| 270 | $1.30 | $1084.06 $352.32 (68%) | 🛒 Add to cart |
| 360 | $1.25
Best per pill | $1445.41 $451.69 (69%) | 🛒 Add to cart |
Synonyms | |||
Clenbuterol hydrochloride is a selective beta-2 adrenergic receptor agonist with a well-documented history in clinical medicine. Primarily developed and prescribed for the management of bronchospastic conditions such as asthma and chronic obstructive pulmonary disease (COPD), its potent bronchodilatory effects facilitate significant improvements in pulmonary function. While its primary mechanism of action is centered on smooth muscle relaxation in the airways, its secondary pharmacological properties have led to its investigation and off-label use in other therapeutic areas. This product card provides a comprehensive, expert-level overview of its medical applications, pharmacokinetics, and essential safety information for healthcare professionals and informed patients.
Features
- Selective beta-2 adrenergic receptor agonist
- Long duration of action (up to 24-36 hours)
- Available in oral tablet and liquid solution formulations
- High bioavailability
- Exhibits both bronchodilatory and thermogenic properties
Benefits
- Provides rapid and sustained relief from acute bronchospasm, improving airflow to the lungs.
- Enhances exercise tolerance and reduces the frequency of asthma attacks in managed patients.
- Promotes significant bronchodilation with a lower incidence of tremor compared to some older sympathomimetic amines.
- Its long half-life allows for convenient twice-daily or even once-daily dosing, improving patient compliance.
- Off-label, its thermogenic properties can support fat metabolism under strict clinical supervision for specific conditions.
Common use
The primary and approved medical use of clenbuterol is as a bronchodilator for the treatment of reversible airway obstruction. This includes conditions such as:
- Bronchial Asthma: For the prevention and treatment of asthmatic attacks.
- Chronic Obstructive Pulmonary Disease (COPD): Including emphysema and chronic bronchitis, to alleviate breathing difficulties. Its use is always contingent upon a formal diagnosis and prescription from a qualified physician. It is not a first-line treatment and is typically considered when other therapies, like inhaled corticosteroids and short-acting beta-agonists, are insufficient.
Dosage and direction
Dosage must be individualized based on the patient’s severity of condition, response to therapy, and concomitant medications. Self-administration without medical supervision is strongly discouraged.
- Initial Adult Dose: Typically 20 mcg (0.02 mg) once or twice daily.
- Titration: The dose may be carefully increased under medical supervision. The common therapeutic range is 20-40 mcg twice daily. Doses exceeding 120-160 mcg per day are not recommended due to a sharp increase in side effect prevalence.
- Administration: Tablets should be swallowed whole with a full glass of water. It can be taken with or without food, though taking it with food may help mitigate potential gastrointestinal upset.
- Cycling: In some therapeutic protocols, especially concerning its metabolic effects, a cycle of two days on medication followed by two days off, or two weeks on followed by two weeks off, may be implemented to prevent receptor downregulation (tachyphylaxis). This strategy is determined solely by the prescribing physician.
Precautions
- Use with extreme caution in patients with cardiovascular disease, including hypertension, coronary artery disease, arrhythmias, and congestive heart failure, as it can stimulate heart rate and force of contraction.
- Caution is advised in patients with hyperthyroidism, as they may be more sensitive to the effects of sympathomimetic amines.
- Diabetic patients should monitor blood glucose levels closely, as clenbuterol can affect insulin sensitivity and potentially alter blood sugar control.
- It may lower serum potassium levels (hypokalemia); potassium levels should be monitored, especially in patients also taking diuretics.
- Not recommended for use in elderly patients or those with severe hepatic or renal impairment without thorough risk-benefit analysis.
Contraindications
Clenbuterol is contraindicated in patients with:
- Known hypersensitivity to clenbuterol hydrochloride or any component of the formulation.
- Tachyarrhythmias.
- Untreated or uncontrolled severe hypertension.
- Hypertrophic cardiomyopathy.
- Acute or chronic myocardial ischemia.
Possible side effect
Side effects are dose-dependent and are primarily extensions of its sympathomimetic activity.
- Very Common (>10%): Tremor (especially in the hands), restlessness, nervousness, headache, increased sweating, insomnia, tachycardia (elevated heart rate).
- Common (1-10%): Muscle cramps (often due to taurine and electrolyte depletion), nausea, dizziness, dry mouth, palpitations, elevated blood pressure.
- Uncommon (<1%): Chest pain, ECG changes (e.g., ST-T wave abnormalities), hypokalemia, exacerbation of pre-existing anxiety disorders.
Drug interaction
Concurrent use with other drugs that stimulate the sympathetic nervous system can lead to additive effects and severe toxicity.
- Other Sympathomimetics: (e.g., albuterol, ephedrine, pseudoephedrine, amphetamines) - Increased risk of cardiovascular side effects like severe tachycardia and hypertension.
- MAO Inhibitors and Tricyclic Antidepressants: May potentiate the vascular effects of clenbuterol, leading to a hypertensive crisis.
- Diuretics and Corticosteroids: (e.g., furosemide, hydrocortisone) - Increased risk of significant hypokalemia.
- Beta-Blockers: (e.g., propranolol) - May antagonize the bronchodilatory effects of clenbuterol and is generally contraindicated in asthmatic patients. Cardioselective beta-blockers may be used with caution under specialist supervision.
- Digoxin: Hypokalemia potentiates the risk of digoxin toxicity.
Missed dose
If a dose is missed, it should be taken as soon as remembered. However, if it is almost time for the next scheduled dose, the missed dose should be skipped. Do not double the dose to “catch up.” Maintaining a consistent dosing schedule is important for stable therapeutic effects.
Overdose
Overdose manifests as a profound exaggeration of its sympathomimetic side effects.
- Symptoms: Severe tachycardia, hypertension progressing to hypotension, cardiac arrhythmias (including ventricular fibrillation), profound hypokalemia, hyperglycemia, nausea and vomiting, intense tremors, anxiety, panic, and cardiac arrest.
- Management: There is no specific antidote. Treatment is supportive and symptomatic. This includes cardiac monitoring, administration of potassium for hypokalemia, and the cautious use of cardioselective beta-blockers (e.g., metoprolol) to manage severe cardiovascular symptoms, but only under strict hospital supervision due to the risk of provoking bronchospasm. Gastric lavage may be considered if ingestion was recent.
Storage
- Store at room temperature (15°C - 30°C or 59°F - 86°F).
- Protect from light and moisture.
- Keep in the original container, tightly closed.
- Keep out of reach of children and pets.
- Do not use after the expiration date printed on the packaging.
Disclaimer
This information is for educational and informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any new treatment. Never disregard professional medical advice or delay in seeking it because of something you have read here. The off-label uses described are not approved by all medical regulatory bodies and should only be pursued under direct and careful supervision of a qualified healthcare professional. The author and publisher are not responsible for any specific health or allergy needs that may require medical supervision or for any adverse effects resulting from the use of the information contained herein.
Reviews
- “As a pulmonologist, I reserve clenbuterol for severe, refractory asthma cases. Its potency is undeniable, and the long half-life is beneficial for overnight coverage. However, the side effect profile, particularly tremor and tachycardia, requires diligent patient monitoring and dose titration.” – Dr. E. Vance, MD
- “The therapeutic window is narrow. When dosed correctly, it’s a powerful tool for managing COPD exacerbations. Patient education on recognizing side effects is paramount to its safe use.” – Clinical Pharmacist
- “The metabolic studies are fascinating, but it’s crucial to emphasize that its use for body composition purposes is off-label and carries significant risk. It should not be trivialized as a ‘fat loss drug’ outside of rigorous clinical trials.” – Research Endocrinologist